Press release
Denosumab Market Growth Fueled By Rising Osteoporosis Prevalence: Major Factor in the Transformation of the Denosumab Market in 2025
Construction Management Software Market
The denosumab market is expected to grow from $3.27 billion in 2024 to $3.7 billion in 2025, at a CAGR of 13.1%. Clinical trials, research advancements, and growing awareness of bone health are key drivers.
The denosumab market is expected to grow rapidly, reaching $5.59 billion by 2029, with a CAGR of 10.9%. This growth is attributed to the rising incidence of bone metastases, advancements in cancer therapies, increased awareness of osteoporosis, and regulatory approvals for new indications. Major trends include strategic collaborations, integration with digital health solutions, expanded clinical applications, and advancements in biosimilar development.
What Key Elements Are Boosting Growth in the Denosumab Market?
The increasing prevalence of osteoporosis is expected to drive the growth of the denosumab market. Osteoporosis leads to weak bones and an increased risk of fractures, and denosumab is used to treat it by inhibiting bone resorption. According to the National Center for Biotechnology Information, osteoporosis affects a significant portion of the older population, with 12.7% of women diagnosed with the condition. The growing prevalence of osteoporosis is driving the demand for treatments like denosumab.
Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13835&type=smp
Who Are the Major Industry Players Fueling Denosumab Market Expansion?
Major companies operating in the denosumab market report are Johnson & Johnson, F. Hoffmann-La Roche Ltd., Novartis International AG, Sanofi SA, GlaxoSmithKline plc, Eli Lilly and Company, Amgen Inc., Asahi Kasei Corporation, Teva Pharmaceutical Industries Ltd., Astellas Pharma Inc., Daiichi Sankyo Company, Limited, Mylan N.V., Sandoz International GmbH, Daiichi Sankyo Company Limited, Aurobindo Pharma Limited, Cipla Limited, Dr. Reddy's Laboratories Ltd., Hikma Pharmaceuticals PLC, Celltrion Inc., Amneal Pharmaceuticals Inc, Cadila Healthcare Limited, Lupin Limited, Biocon Limited, Torrent Pharmaceuticals Ltd., Jubilant Life Sciences Limited, Ajanta Pharma Limited
How Is the Segmentation of the Denosumab Market Defined?
The denosumab market covered in this report is segmented -
1) By Drug Classification: Prolia, Xgeva, Others
2) By Type: 60 mg, 120 mg
3) By End-Users: Hospitals, Homecare, Specialty Clinics, Ambulatory Surgical Centers
Pre-Book Your Report Now For A Swift Delivery:
https://www.thebusinessresearchcompany.com/report/denosumab-global-market-report
What Is the Leading Region in the Denosumab Market?
North America was the largest region in the denosumab market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the denosumab market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
What Is Covered In The Denosumab Global Market Report?
- Market Size Analysis: Analyze the Denosumab Market size by key regions, countries, product types, and applications.
- Market Segmentation Analysis: Identify various subsegments within the Denosumab Market for effective categorization.
- Key Player Focus: Focus on key players to define their market value, share, and competitive landscape.
- Growth Trends Analysis: Examine individual growth trends and prospects in the Market.
- Market Contribution: Evaluate contributions of different segments to the overall Denosumab Market growth.
- Growth Drivers: Detail key factors influencing market growth, including opportunities and drivers.
- Industry Challenges: Analyze challenges and risks affecting the Denosumab Market.
- Competitive Developments: Analyze competitive developments, such as expansions, agreements, and new product launches in the market.
Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=13835
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Denosumab Market Growth Fueled By Rising Osteoporosis Prevalence: Major Factor in the Transformation of the Denosumab Market in 2025 here
News-ID: 3848001 • Views: …
More Releases from The Business Research Company
Steady Expansion Forecast for Pharma Grade Cellulose Powder Market, Projected to …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Pharma Grade Cellulose Powder Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
The market size for pharma grade cellulose powder has witnessed robust growth in the past few years. The market value, which stood at $1.47 billion in 2024, is projected to rise to $1.55…
Top Trends Transforming the Oral Rehydration Solution Market Landscape in 2025: …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Will the Oral Rehydration Solution Industry Market Size Be by 2025?
In the past few years, the market size for oral rehydration solutions has seen solid growth. The market is projected to expand from $4.06 billion in 2024 to $4.42 billion in 2025, accounting for a compound annual…
Key Factor Supporting Nausea Medicine Market Development in 2025: Rising Consump …
"Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
How Large Will the Nausea Medicine Market Size By 2025?
The market size for anti-nausea medication has experienced robust growth in the last few years. It's predicted that the market will escalate from $3.02 billion in 2024 to $3.22 billion in 2025, exhibiting a compound annual growth rate (CAGR)…
Future of the Pharmaceuticals Native Starch Market: Trends, Innovations, and Key …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Pharmaceuticals Native Starch Market Size Growth Forecast: What to Expect by 2025?
The market size of native starch in the pharmaceutical industry has witnessed considerable growth in recent years. The market size is anticipated to surge from $5.65 billion in 2024 to $6.11 billion in 2025, marking a compound…
More Releases for Denosumab
Denosumab Market Growth Fueled By Rising Osteoporosis Prevalence: Strategic Insi …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
How Large Will the Denosumab Market Size By 2025?
The market for denosumab has seen significant expansion in recent times. The growth is expected to rise from $3.27 billion in 2024 to $3.67 billion in 2025, portraying a compound annual growth rate (CAGR) of 12.1%. The increase during the…
Denosumab Market Growth Fueled By Rising Osteoporosis Prevalence: A Key Driver P …
The Denosumab Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Current Denosumab Market Size and Its Estimated Growth Rate?
The market size of denosumab has seen a fast-paced expansion in the past few years. It is projected to surge from $3.27 billion in…
Denosumab Market Size, Share, Trends, Insights And Forecast To 2033
The Business Research Company recently released a comprehensive report on the Global Denosumab Market Size and Trends Analysis with Forecast 2024-2033. This latest market research report offers a wealth of valuable insights and data, including global market size, regional shares, and competitor market share. Additionally, it covers current trends, future opportunities, and essential data for success in the industry.
According to The Business Research Company's, The denosumab market size has grown…
Denosumab Market Key Trends, Insights, Analysis 2024-2033: A Comprehensive Repor …
"The new report published by The Business Research Company, titled "" Denosumab Global Market Report 2024 - Market Size, Trends, And Global Forecast 2024-2033"", delivers an in-depth analysis of the leading size and forecasts, investment opportunities, winning strategies, market drivers and trends, competitive landscape, and evolving market trends.
As per the report, the denosumab market size has grown rapidly in recent years. It will grow from $2.89 billion in 2023…
Denosumab Global Market Analysis, Trends, Growth, Research And Forecast 2033
The denosumab market size has grown rapidly in recent years. It will grow from $2.89 billion in 2023 to $3.27 billion in 2024 at a compound annual growth rate (CAGR) of 13.2%. The growth in the historic period can be attributed to clinical trials and research advancements, FDA approvals and regulatory milestones, growing awareness of bone health, strategic partnerships and marketing initiatives.
The denosumab market size is expected to see…
Denosumab Market Report, Size, Share And Analysis 2024-2033
The Business Research Company has released its latest global market reports, covering insights for 2024 and offering projections up to 2033.
The Business Research Company presents an extensive market research report on the Denosumab Global Market Report 2024, furnishing businesses with a competitive edge through a detailed examination of the market structure, encompassing estimates for various segments and sub-segments.
Furthermore, the report highlights on emerging trends, significant drivers, challenges, and opportunities, providing…
